Gundaya, Cresencia .

HRN: 27-62-23  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
08/10/2025
PIPERACILLIN + TAZOBACTAM 4.5G (VLS)
08/10/2025
08/17/2025
IV
4.5
Q8
Sepsis Probably Sec To Complicated UTI
Checking Initial Appropriateness 

 Indication:  ProphylaxisEmpiric    Type of Infection:  Urinary Tract    Compliance to guidelines: Compliant To Guidelines